Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management.

ABSTRACT:

Introduction

In recognition of the value of long-term real-world data, a postauthorization safety study of the inhaled corticosteroid (ICS) fluticasone propionate and long-acting β₂-agonist (LABA) formoterol fumarate (fluticasone/formoterol; Flutiform^®) was conducted.

Methods

This was a 12-month observational study of outpatients with asthma aged ⩾ 12 years in eight European countries. Patients were prescribed fluticasone/formoterol according to the licensed indication, and independently of their subsequent enrolment in the study. They were then treated according to local standard practice. The study objectives were to evaluate the safety and effectiveness of fluticasone/formoterol under real-world conditions.

Results

The safety population for th

SUBMITTER: Backer V 

PROVIDER: S-EPMC6149027 | biostudies-literature | 2018 Jan-Dec

REPOSITORIES: biostudies-literature